Anna Laurén

Clinicogenomic factors of biotherapy immunogenicity in autoimmune disease: A prospective multicohort study of the ABIRISK consortium

Signe Hässler, Delphine Bachelet, Julianne Duhazé et al. · PLoS Medicine · 2020 · 55 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Safety and pharmacokinetics of a glycoPEGylated recombinant activated factor VII derivative: a randomized first human dose trial in healthy subjects

Judi Møss, Anders Rosholm, Anna Laurén · Journal of Thrombosis and Haemostasis · 2011 · 35 citations

Pharmacy, Pharmacokinetics, Pharmacology +13

A Strategic Approach to Nonclinical Immunogenicity Assessment: A Recommendation from the European Bioanalysis Forum

Anna Laurén, Joanne Goodman, Jonas Blaes et al. · Bioanalysis · 2021 · 20 citations

Pharmacy, Immunology, Clinical Immunology +12

Quantitative polymerase chain reaction in the bioanalytical laboratory and technical and scientific considerations for nonclinical and clinical assay characterization, validation and sample analysis

Anna Laurén, Manuela Braun, Chiara Cazzin et al. · Bioanalysis · 2022 · 13 citations

Natural Sciences, Chemistry, Analytical Chemistry +16

Comparative studies on mucosal and intravenous transmission of simian immunodeficiency virus (SIVsm): the kinetics of evolution to neutralization resistance are related to progression rate of disease

Anna Laurén, Rigmor Thorstensson, Éva Mária Fenyõ · Journal of General Virology · 2006 · 12 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +13